The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | R | Respiratory system | |
| 2 | R01 | Nasal preparations | |
| 3 | R01B | Nasal decongestants for systemic use | |
| 4 | R01BA | Sympathomimetics | |
| 5 | R01BA52 | Pseudoephedrine, combinations |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ACTIFED Syrup | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| MEDOFED Oral solution | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| ZYRTEC-D Prolonged release tablet | Marketing Authorisation Holder | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
